Michael J. McElhaugh
CIK: 0001635326
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABUS
Arbutus Biopharma Corp
DirectorOfficer
Discretionary Trading P&L
Holdings
About McElhaugh Michael J.
McElhaugh Michael J. (SEC CIK 0001635326) files insider reports with the SEC as Interim President & CEO of Arbutus Biopharma Corp (ABUS).
Signal8 holds 2 ownership filings by McElhaugh Michael J., all Form 4s, filed between Feb 5, 2025 and Feb 19, 2025. Those filings report 2 transactions, from Feb 4, 2025 to Feb 14, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on McElhaugh Michael J.'s filings is in WARMINSTER, PA.
Recent filings by McElhaugh Michael J.
Other insiders filing for Arbutus Biopharma Corp (ABUS)
- Beardsley Robert A, Director
- Nguyen Tuan, Chief Financial Officer
- Sawhney Roger, Director
- Androski Lindsay, President and CEO
- Hasija Anuj, Director
- Bishop Joseph E, Director